2-[4-(3,4-二氯苄氧基)苯乙醇 | 188928-11-2

• 分子结构分类: 有机化合物 - 苯类化合物 - 酚类
• 中文名称: 2-[4-(3,4-二氯苄氧基)苯乙醇
• 英文名称: 2-(4-(3,4-dichlorobenzyloxy)phenyl)ethanol
• 英文别名: 2-[4-(3,4-Dichlorobenzyloxy)phenylethanol；2-[4-[(3,4-dichlorophenyl)methoxy]phenyl]ethanol
• CAS: 188928-11-2
• 化学式: C₁₅H₁₄Cl₂O₂
• 分子量: 297.181
• InChiKey: ODXXRJUWIQJJJX-UHFFFAOYSA-N

物化性质

• 沸点：
  433.3±40.0 °C(Predicted)
• 密度：
  1.301±0.06 g/cm3(Predicted)
• 溶解度：
  可溶于丙酮、氯仿、二氯甲烷、乙酸乙酯、甲醇

计算性质

• 辛醇/水分配系数(LogP)：
  4.2
• 重原子数：
  19
• 可旋转键数：
  5
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.2
• 拓扑面积：
  29.5
• 氢给体数：
  1
• 氢受体数：
  2

反应信息

• 作为反应物：
  描述：

  2-[4-(3,4-二氯苄氧基)苯乙醇 在 2,2,6,6-四甲基哌啶氧化物 、 sodium bromite trihydrate 、 碳酸氢钠 作用下， 以 二氯甲烷 、 水 为溶剂， 反应 0.5h， 以64%的产率得到2-(4-(3,4-dichlorobenzyloxy)phenyl)acetaldehyde
  参考文献：
  名称：

  Design, synthesis and anti-tubercular evaluation of new 2-acylated and 2-alkylated amino-5-(4-(benzyloxy)phenyl)thiophene-3-carboxylic acid derivatives. Part 1

  摘要：

  A series of 2-acylated and 2-alkylated amino-5-(4-(benzyloxy)phenyl)thiophene-3-carboxylic acid derivatives were synthesized and evaluated for anti-tubercular activity. Among these compounds, 10d, 15, 12h and 12k inhibited Mycobacterium tuberculosis (Mtb) growth with MIC values between 1.9 and 7.7 mu M and low toxicity against VERO cells. The four compounds were also tested against multidrug-resistant tuberculosis (MDR-TB) and extensively drug-resistant tuberculosis (XDR-TB) clinical strains, which were found to show moderate activity. In addition, molecular docking simulation was performed to position compounds 10d, 15, 12h and 12k into mtFabH active site to predict the probable binding mode. These studies thus suggest that the designed 2-amino-5-phenylthiophene-3-carboxylic acid scaffold may serve as new promising template for further elaboration as anti-TB drugs. (C) 2011 Elsevier Masson SAS. All rights reserved.

  DOI：

  10.1016/j.ejmech.2011.05.018
• 作为产物：
  描述：

  对羟基苯乙醇 、 3,4-二氯氯苄 在 potassium carbonate 作用下， 以 丙酮 为溶剂， 反应 24.0h， 以83%的产率得到2-[4-(3,4-二氯苄氧基)苯乙醇
  参考文献：
  名称：

  Design, synthesis and anti-tubercular evaluation of new 2-acylated and 2-alkylated amino-5-(4-(benzyloxy)phenyl)thiophene-3-carboxylic acid derivatives. Part 1

  摘要：

  A series of 2-acylated and 2-alkylated amino-5-(4-(benzyloxy)phenyl)thiophene-3-carboxylic acid derivatives were synthesized and evaluated for anti-tubercular activity. Among these compounds, 10d, 15, 12h and 12k inhibited Mycobacterium tuberculosis (Mtb) growth with MIC values between 1.9 and 7.7 mu M and low toxicity against VERO cells. The four compounds were also tested against multidrug-resistant tuberculosis (MDR-TB) and extensively drug-resistant tuberculosis (XDR-TB) clinical strains, which were found to show moderate activity. In addition, molecular docking simulation was performed to position compounds 10d, 15, 12h and 12k into mtFabH active site to predict the probable binding mode. These studies thus suggest that the designed 2-amino-5-phenylthiophene-3-carboxylic acid scaffold may serve as new promising template for further elaboration as anti-TB drugs. (C) 2011 Elsevier Masson SAS. All rights reserved.

  DOI：

  10.1016/j.ejmech.2011.05.018

文献信息

• Design, synthesis and anti-tubercular evaluation of new 2-acylated and 2-alkylated amino-5-(4-(benzyloxy)phenyl)thiophene-3-carboxylic acid derivatives. Part 1
  作者：Xiaoyun Lu、Baojie Wan、Scott G. Franzblau、Qidong You

  DOI：10.1016/j.ejmech.2011.05.018

  日期：2011.9

  A series of 2-acylated and 2-alkylated amino-5-(4-(benzyloxy)phenyl)thiophene-3-carboxylic acid derivatives were synthesized and evaluated for anti-tubercular activity. Among these compounds, 10d, 15, 12h and 12k inhibited Mycobacterium tuberculosis (Mtb) growth with MIC values between 1.9 and 7.7 mu M and low toxicity against VERO cells. The four compounds were also tested against multidrug-resistant tuberculosis (MDR-TB) and extensively drug-resistant tuberculosis (XDR-TB) clinical strains, which were found to show moderate activity. In addition, molecular docking simulation was performed to position compounds 10d, 15, 12h and 12k into mtFabH active site to predict the probable binding mode. These studies thus suggest that the designed 2-amino-5-phenylthiophene-3-carboxylic acid scaffold may serve as new promising template for further elaboration as anti-TB drugs. (C) 2011 Elsevier Masson SAS. All rights reserved.